Honest Stock Talk

Just a guy talking about stocks and giving honest opinons

[Honest Stock Talk @StockHonest]

@centrino12345 @BrandonVanZee @dividendhike You’re short minded man. 0.93% with 10% annual growth is better then a 7% with no growth 😂😂

[Honest Stock Talk @StockHonest]

@BigLgChewbacca @DividendBulls I would have said that about most stocks this year, but they all keep tanking

[Honest Stock Talk @StockHonest]

@DividendBulls I definitely see the appeal. I just never pulled the trigger on them. I get nervous when revenue starts to stagnant. Or slow down a lot.

[Honest Stock Talk @StockHonest]

@DividendBulls May I ask what you like about $CWEN. Their company just doesn’t seem to be doing insanely good. After 2016 their growth YOY has been less than stellar.

[Honest Stock Talk @StockHonest]

Why does no one in the #dividend community talk about $GILD Gilead science when they practically own anti-viral therapies ?

[Honest Stock Talk @StockHonest]

How many tweets on the same 20 stocks will we see today? No one does research on different stuff these days. Stagnation #finance #stocks #investing

[Honest Stock Talk @StockHonest]

It would appear as though $APD did not screw me over. #stocks #dividend #investing

[Honest Stock Talk @StockHonest]

The real question is does $APD kill my stellar gains for the past 3 months? Or does it send it beyond. Stay tuned #stocks #earningsweek #dividends #finance

[Honest Stock Talk @StockHonest]

$APD will be reporting tomorrow. Looking for that 20% YOY revenue growth. Got a sizable chunk in this and my conviction is high. #stocks #dividends #earnings #portoflio

[Honest Stock Talk @StockHonest]

I also think that $ENTG has a good group in lead. Their CEO has the right mindset about their future. #stocks #investments #growthstocks

[Honest Stock Talk @StockHonest]

@SteveWagsInvest $CAT and $APD weighted at 8% each.

[Honest Stock Talk @StockHonest]

My most bullish prediction is $ENTG to $160 right now. The company has had insane sustained growth and financials look well off considering. Their most recent EPS growth missed by 5% but their revenue is at %26 YOY growth for 21/22. How is that not insane?

[Honest Stock Talk @StockHonest]

@Blind__Luck Me and Powell

[Honest Stock Talk @StockHonest]

@Scott35342155 @Dividend_Dollar I’ll check it out when I get off work. I’m just riding on the industrial sector right now. Never been too big into companies like Ares, but I’ll totally look into it and get back to you

[Honest Stock Talk @StockHonest]

@Scott35342155 @Dividend_Dollar I’ve been buying lots of $APD and $AWK recently. My original point though is Ares is an awful play and they other two pharma companies are extremely risky in the pharmaceutical climate right now

[Honest Stock Talk @StockHonest]

@Scott35342155 @Dividend_Dollar Some of those lack growth in EPS/Revenue compared to companies with outstanding growth. I’m high in industrials right now so companies like $CAT, $PH, $APD, and $ENTG are huge players for me. I just don’t like pharma due to how quick stagnation occurs, especially in now days

[Honest Stock Talk @StockHonest]

@Scott35342155 @Dividend_Dollar Lastly I think companies like EPD are also highly cyclical and only good for dividends, but if that’s the reason for buying you would be better off distributing into $JEPI and gaining a diversified monthly payment without the enormous risk of cyclical companies.

[Honest Stock Talk @StockHonest]

@Scott35342155 @Dividend_Dollar Personally I stay away from pharma companies all together due to this. I also have a few years in the business of toxicology and nursing so I have an idea what’s up. I would instead trade that out for a supplier or healthcare service or supply. $HCA is a major player for example